Table of Content

1. Report Overview
1.1 Introduction to Real-World Evidence Solutions Market
1.2 Real-World Evidence Solutions Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)

2 Executive Summary
2.1 Market Outlook

3 Industry Insights
3.1 Drivers
3.1.1 Increasing use of Bigdata in Healthcare Industry
3.1.2 Growing use of smart wearables, sensors, and devices which collect real world data
3.1.3 Usage of RWE in Biopharma
3.1.4 RWE Can Enhance Clinical Trials
3.2 Restraints
3.2.1 Patient Privacy Issues
3.2.2 Lack of adequate financing and high capital investments
3.3 Opportunities
3.3.1 Increasing adoption of Patient-Centric Programs
3.3.2 Long-Term Outlook for Chronic Disease Management
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Industry analysis - Porter’s
3.5.1 Bargaining Power of Buyer to Have Low Impact
3.5.2 Bargaining Power of Supplier to Have High Impact
3.5.3 Competitive Rivalry is Medium
3.5.4 Threat of Substitutes if Low
3.5.5 High Threat from New Entrants

4 Real-World Evidence Solutions Market by Component
4.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
4.2 Data Gathering in Healthcare is Growing at Exponential Rates
4.3 Services Such as Drug Effects & Drug Utilization to Offer Lucrative Growth Opportunities

5 Real-World Evidence Solutions Market by Datasets
5.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
5.2 Clinical Settings Data offers Organizations with Efficient Clinical Care
5.3 Claims Data to Strengthen RWE Market
5.4 Pharmacy Data to Garner Huge Demand from Pharmaceutical Companies
5.5 Patient-Powered Data Which Fosters Data Sharing Partnership to Fuel Market Growth

6 Real-World Evidence Solutions Market by Therapeutic Area
6.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
6.2 Oncology Segment to Garner Maximum Market Share
6.3 Cardiovascular Diseases: Usage of RWE to Offer Better Safety & Effectiveness in CVDs Drugs
6.4 Neurology: Role of RWE in Neurology Research
6.5 Immunology Segment to Witness Lucrative Growth
6.6 Other Therapeutic Areas

7 Real-World Evidence Solutions Market by End-Users
7.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
7.2 Healthcare Payers: Rising Need of Privacy and Security Concerns
7.3 Healthcare Providers: Growing Usage of EHR to Support Market Growth
7.4 Pharmaceutical & Medical Device Companies to Witness Highest Growth Rate Owing to Growing Demand for Accelerated Drug Approval Process
7.5 Other End-Users

8 Regional and Leading National Real-World Evidence Solutions Market Forecasts 2020-2030
8.1 Global Real-World Evidence Solutions Market by Region Forecast 2020-2030
8.2 Recovery Scenarios by Region

9 North America
9.1 Increasing Prevalence of Chronic Diseases
9.2 North America Real-World Evidence Solutions Market by Country Forecast 2020-2030
9.3 North America Real-World Evidence Solutions Market Forecast by Component
9.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
9.3.2 Services Segment Revenue and Forecast, 2020-2030
9.4 North America Real-World Evidence Solutions Market Forecast by Datasets
9.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
9.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
9.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
9.4.4 Patient-Powered Data Segment Revenue and Forecast, 2020-2030
9.5 North America Real-World Evidence Solutions Market Forecast by Therapeutic Area
9.5.1 Oncology Segment Revenue and Forecast, 2020-2030
9.5.2 CVDs Segment Revenue and Forecast, 2020-2030
9.5.3 Neurology Segment Revenue and Forecast, 2020-2030
9.5.4 Immunology Segment Revenue and Forecast, 2020-2030
9.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
9.6 North America Real-World Evidence Solutions Market Forecast by End-Users
9.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
9.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
9.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
9.6.4 Other End Users Revenue and Forecast, 2020-2030
9.7 U.S. Real-World Evidence Solutions Market Forecast 2020-2030
9.7.1 U.S. Has one of the Advanced Healthcare System in the World
9.7.2 Recovery Scenarios (V, U, W, L): U.S. Real-World Evidence Solutions Market Forecast, 2020-2030
9.8 Canada Real-World Evidence Solutions Market Forecast 2020-2030
9.8.1 Canada is Developing Essential Infrastructure to Collect Real-World Insights
9.8.2 Recovery Scenarios (V, U, W, L): Canada Real-World Evidence Solutions Market Forecast, 2020-2030

10 Europe
10.1 RWE in Europe is Being Used for Fast-Tracked Access to Drugs
10.2 Europe Real-World Evidence Solutions Market by Country Forecast 2020-2030
10.3 Europe Real-World Evidence Solutions Market Forecast by Component
10.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
10.3.2 Services Segment Revenue and Forecast, 2020-2030
10.4 Europe Real-World Evidence Solutions Market Forecast by Datasets
10.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
10.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
10.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
10.4.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
10.5 Europe Real-World Evidence Solutions Market Forecast by Therapeutic Area
10.5.1 Oncology Segment Revenue and Forecast, 2020-2030
10.5.2 CVDs Segment Revenue and Forecast, 2020-2030
10.5.3 Neurology Segment Revenue and Forecast, 2020-2030
10.5.4 Immunology Segment Revenue and Forecast, 2020-2030
10.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
10.6 Europe Real-World Evidence Solutions Market Forecast by End-Users
10.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
10.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
10.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
10.6.4 Other End Users Revenue and Forecast, 2020-2030
10.7 Germany Real-World Evidence Solutions Market Forecast 2020-2030
10.7.1 Growing Acceptance of RWE
10.7.2 Recovery Scenarios (V, U, W, L): Germany Real-World Evidence Solutions Market Forecast, 2020-2030
10.8 France Real-World Evidence Solutions Market Forecast 2020-2030
10.8.1 Introduction
10.8.2 Recovery Scenarios (V, U, W, L): France Real-World Evidence Solutions Market Forecast, 2020-2030
10.9 UK Real-World Evidence Solutions Market Forecast 2020-2030
10.9.1 UK Plays an Important Role in Real World Data Capacity
10.9.2 Recovery Scenarios (V, U, W, L): UK Real-World Evidence Solutions Market Forecast, 2020-2030
10.10 Italy Real-World Evidence Solutions Market Forecast 2020-2030
10.10.1 Huge Market Potential
10.10.2 Recovery Scenarios (V, U, W, L): Italy Real-World Evidence Solutions Market Forecast, 2020-2030
10.11 Spain Real-World Evidence Solutions Market Forecast 2020-2030
10.11.1 RWE Solutions to Reform Healthcare System in Spain
10.11.2 Recovery Scenarios (V, U, W, L): Spain Real-World Evidence Solutions Market Forecast, 2020-2030
10.12 Rest of Europe Real-World Evidence Solutions Market Forecast 2020-2030
10.12.1 Significant Growth Opportunities for RWE Players Across the Region
10.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030

11 Asia Pacific
11.1 Asia Pacific RWE Market to Witness Highest Growth Rate
11.2 Asia Pacific Real-World Evidence Solutions Market by Country Forecast 2020-2030
11.3 Asia Pacific Real-World Evidence Solutions Market Forecast by Component
11.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
11.3.2 Services Segment Revenue and Forecast, 2020-2030
11.4 Asia Pacific Real-World Evidence Solutions Market Forecast by Datasets
11.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
11.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
11.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
11.4.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
11.5 Asia Pacific Real-World Evidence Solutions Market Forecast by Therapeutic Area
11.5.1 Oncology Segment Revenue and Forecast, 2020-2030
11.5.2 CVDs Segment Revenue and Forecast, 2020-2030
11.5.3 Neurology Segment Revenue and Forecast, 2020-2030
11.5.4 Immunology Segment Revenue and Forecast, 2020-2030
11.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
11.6 Asia Pacific Real-World Evidence Solutions Market Forecast by End-Users
11.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
11.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
11.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
11.6.4 Other End Users Revenue and Forecast, 2020-2030
11.7 Japan Real-World Evidence Solutions Market Forecast 2020-2030
11.7.1 Japan is One of The Leading Countries to Adopt RWE Solutions
11.7.2 Recovery Scenarios (V, U, W, L): Japan Real-World Evidence Solutions Market Forecast, 2020-2030
11.8 China Real-World Evidence Solutions Market Forecast 2020-2030
11.8.1 China Projected to Witness Substantial Challenges
11.8.2 Recovery Scenarios (V, U, W, L): China Real-World Evidence Solutions Market Forecast, 2020-2030
11.9 India Real-World Evidence Solutions Market Forecast 2020-2030
11.9.1 India is Facing a lot of Difficulty in Implementing RWE Due to Lack of Data Collection Platform and Sources
11.9.2 Recovery Scenarios (V, U, W, L): India Real-World Evidence Solutions Market Forecast, 2020-2030
11.10 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast 2020-2030
11.10.1 Introduction
11.10.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030

12 Rest of the World
12.1 RoW Real-World Evidence Solutions Market Forecast by Component
12.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
12.3.2 Services Segment Revenue and Forecast, 2020-2030
12.2 RoW Real-World Evidence Solutions Market Forecast by Datasets
12.2.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
12.2.2 Claims Data Segment Revenue and Forecast, 2020-2030
12.2.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
12.2.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
12.3 RoW Real-World Evidence Solutions Market Forecast by Therapeutic Area
12.3.1 Oncology Segment Revenue and Forecast, 2020-2030
12.3.2 CVDs Segment Revenue and Forecast, 2020-2030
12.3.3 Neurology Segment Revenue and Forecast, 2020-2030
12.3.4 Immunology Segment Revenue and Forecast, 2020-2030
12.3.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
12.4 RoW Real-World Evidence Solutions Market Forecast by End-Users
12.4.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
12.4.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
12.4.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
12.4.4 Other End Users Revenue and Forecast, 2020-2030
12.5 RoW Real-World Evidence Solutions Market Forecast 2020-2030
12.5.1 Recovery Scenarios (V, U, W, L): RoW Real-World Evidence Solutions Market Forecast, 2020-2030

13 Leading Companies
13.1 Iqvia
13.1.1 Company Snapshot, 2020
13.1.2 Company Overview
13.1.3 Financial Analysis, 2015-2019
13.1.4 Products
13.1.5 Recent Developments, 2018-2019
13.2 IBM
13.2.1 Company Snapshot, 2020
13.2.2 Company Overview
13.2.3 Financial Analysis, 2015-2019
13.2.4 Products
13.2.5 Recent Developments, 2020
13.3 Pharmaceutical Product Development (PPD)
13.3.1 Company Snapshot, 2020
13.3.2 Company Overview
13.3.3 Products
13.4 PAREXEL
13.4.1 Company Snapshot, 2020
13.4.2 Company Overview
13.4.3 Products
13.4.4 Recent Developments, 2020
13.5 Optum (Subsidiary of United Health Group, Inc.)
13.5.1 Company Snapshot, 2020
13.5.2 Company Overview
13.5.3 Financial Analysis, 2015-2019
13.5.4 Products
13.5.5 Recent Developments, 2020
13.6 PerkinElmer Inc.
13.6.1 Company Snapshot, 2020
13.6.2 Company Overview
13.6.3 Financial Analysis, 2015-2019
13.6.4 Products
13.7 Icon PLC
13.7.1 Company Snapshot, 2020
13.7.2 Company Overview
13.7.3 Financial Analysis, 2015-2019
13.7.4 Products
13.8 Anthem
13.8.1 Company Snapshot, 2020
13.8.2 Company Overview
13.8.3 Financial Analysis, 2015-2019
13.8.4 Products
13.9 Oracle
13.9.1 Company Snapshot, 2020
13.9.2 Company Overview
13.9.3 Financial Analysis, 2015-2019
13.9.4 Products
13.9.5 Recent Developments, 2019
13.10 Cognizant
13.10.1 Company Snapshot, 2020
13.10.2 Company Overview
13.10.3 Financial Analysis, 2015-2019
13.10.4 Recent Developments, 2019
13.11 Syneos Health
13.11.1 Company Snapshot, 2020
13.11.2 Company Overview
13.11.3 Financial Analysis, 2015-2019
13.11.4 Products
13.11.5 Recent Developments, 2018-2020
13.12 Clinigen
13.12.1 Company Snapshot, 2020
13.12.2 Company Overview
13.12.3 Financial Analysis, 2015-2019
13.12.4 Products
13.13 Covance Inc.
13.13.1 Company Snapshot, 2020
13.13.2 Company Overview
13.13.3 Financial Analysis, 2015-2019
13.13.4 Products
13.13.5 Recent Developments, 2018-2019

14 Conclusion and Recommendations
14.1 Concluding Remarks
14.2 Recommendations

List of Tables


Table 1 Global Real-World Evidence Solutions Market Snapshot, 2020 & 2030 (US$ million, CAGR %)
Table 2 Global Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 3 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 4 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 9 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 14 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 15 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 20 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 25 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 30 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Real-World Evidence Market by Formulation Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 35 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 36 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 41 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 46 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 51 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 56 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 61 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 62 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 65 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 66 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 67 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 72 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 73 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 74 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 75 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 76 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 77 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 82 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%); “U” Shaped Recovery
Table 84 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 85 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 86 North America Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 87 North America Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 88 North America Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 89 North America Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 90 North America Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 91 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 92 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 97 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 102 Europe Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 103 Europe Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 104 Europe Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 105 Europe Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 106 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 107 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 108 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 109 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 110 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 111 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 112 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 113 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 114 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 115 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 116 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 117 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 118 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 119 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 120 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 121 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 122 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 123 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 124 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 125 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 126 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 127 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 128 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 129 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 130 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 131 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 132 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 133 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 134 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 135 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 136 Asia Pacific Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 137 Asia Pacific Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 138 Asia Pacific Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 139 Asia Pacific Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 140 Asia Pacific Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 141 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 142 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 143 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 144 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 145 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 146 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 147 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 152 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 157 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 RoW Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 162 RoW Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 163 RoW Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 164 RoW Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 165 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 166 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 167 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 168 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 169 Iqvia: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 170 Iqvia: Product Portfolio
Table 171 IBM: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 IBM: Product Portfolio
Table 173 Pharmaceutical Product Development (PPD): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 174 Pharmaceutical Product Development (PPD): Product Portfolio
Table 175 Parexel: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 176 Parexel: Product Portfolio
Table 177 Optum (Subsidiary of United Health Group, Inc.): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 178 Optum (Subsidiary of United Health Group, Inc.): Product Portfolio
Table 179 PerkinElmer Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 180 PerkinElmer Inc.: Product Portfolio
Table 181 Icon PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 182 Icon PLC: Product Portfolio
Table 183 Anthem: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 184 Anthem: Product Portfolio
Table 1 Oracle: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 185 Oracle: Product Portfolio
Table 186 Cognizant: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 187 Syneos Health: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 188 Syneos Health: Product Portfolio
Table 189 Clinigen: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 190 Clinigen: Product Portfolio
Table 191 Covance Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 192 Covance Inc.: Product Portfolio

List of Figures


Figure 1 Global Real-World Evidence Solutions Market: Drivers, Restraints & Opportunities
Figure 2 Porter’s Analysis
Figure 3 Global Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR %)
Figure 4 Global Real-World Evidence Solutions Market Share Forecast by Component, 2020, 2025, 2030 (%)
Figure 5 Global Real-World Evidence Solutions Market for Data Sets Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 6 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 7 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 8 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 9 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 10 Global Real-World Evidence Solutions Market for Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 11 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 12 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 13 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 14 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 15 Global Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR %)
Figure 16 Global Real-World Evidence Solutions Market Share Forecast by Datasets, 2020, 2025, 2030 (%)
Figure 17 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 18 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 19 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 20 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 21 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 22 Global Real-World Evidence Solutions Market for Claims Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 23 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 24 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 25 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 26 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 27 Global Real-World Evidence Solutions Market for Pharmacy Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 28 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 29 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 30 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 31 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 32 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 33 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 34 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 35 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 36 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 37 Global Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Figure 38 Global Real-World Evidence Solutions Market Share Forecast by Therapeutic Area, 2020, 2025, 2030 (%)
Figure 39 Global Real-World Evidence Solutions Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 40 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 41 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 42 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 43 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 44 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 45 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 46 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 47 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 48 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 49 Global Real-World Evidence Solutions Market for Neurology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 50 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 51 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 52 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 53 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 54 Global Real-World Evidence Solutions Market for Immunology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 55 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 56 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 57 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 58 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 59 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 60 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 61 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 62 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 63 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 64 Global Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR %)
Figure 65 Global Real-World Evidence Solutions Market Share Forecast by End-Users, 2020, 2025, 2030 (%)
Figure 66 Global Real-World Evidence Solutions Market for Healthcare Payers Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 67 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 68 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 69 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 70 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 71 Global Real-World Evidence Solutions Market for Healthcare Providers Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 72 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 73 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 74 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 75 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 76 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 77 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 78 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 79 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 80 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 81 Global Real-World Evidence Solutions Market for Other End-Users Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 82 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 83 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 84 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 85 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 86 Global Real-World Evidence Solutions Market Forecast by Region 2020-2030 (US$ million)
Figure 87 Global Real-World Evidence Solutions Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 88 North America Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
Figure 89 North America Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 90 North America Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
Figure 91 North America Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
Figure 92 North America Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 93 North America Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 94 U.S. Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 95 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 96 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 97 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 98 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 99 Canada Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 100 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 101 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 102 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 103 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 104 Europe Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
Figure 105 Europe Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 106 Europe Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
Figure 107 Europe Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
Figure 108 Europe Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 109 Europe Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 110 Germany Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 111 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 112 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 113 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 114 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 115 France Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 116 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 117 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 118 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 119 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 120 UK Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 121 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 122 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 123 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 124 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 125 Italy Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 126 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 127 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 128 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 129 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 130 Spain Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 131 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 Rest of Europe Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 136 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 Asia Pacific Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
Figure 141 Asia Pacific Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 142 Asia Pacific Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
Figure 143 Asia Pacific Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
Figure 144 Asia Pacific Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 145 Asia Pacific Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 146 Japan Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 147 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 148 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 149 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 150 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 151 China Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 152 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 153 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 154 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 155 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 156 India Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 157 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 158 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 159 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 160 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 161 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 162 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 163 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 164 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 165 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 166 RoW Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
Figure 167 RoW Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
Figure 168 RoW Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 169 RoW Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 170 RoW Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
Figure 171 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “V” Shaped Recovery
Figure 172 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “U” Shaped Recovery
Figure 173 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “W” Shaped Recovery
Figure 174 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): “L” Shaped Recovery
Figure 175 Iqvia: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 176 Iqvia: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 177 Iqvia: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 178 Iqvia: Segmental Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 179 IBM: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 180 IBM: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 181 IBM: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 182 Optum (Subsidiary of United Health Group, Inc.): Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 183 Optum (Subsidiary of United Health Group, Inc.): EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 184 Optum (Subsidiary of United Health Group, Inc.): Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 185 PerkinElmer Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 186 PerkinElmer Inc.: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 187 PerkinElmer Inc.: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 188 Icon PLC: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 189 Icon PLC: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 190 Icon PLC: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 191 Anthem: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 192 Anthem: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 193 Anthem: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 194 Oracle: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 195 Oracle: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 196 Oracle: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 197 Cognizant: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 198 Cognizant: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 199 Cognizant: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 200 Syneos Health: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 201 Syneos Health: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 202 Syneos Health: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 203 Clinigen: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 204 Clinigen: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 205 Clinigen: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 206 Covance Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 207 Covance Inc.: Gross Profit, 2015-2019 (US$ Mn, AGR%)